Switzerland is home to many pharmaceutical companies, including very large groups such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies have their international headquarters (and 29 more their regional headquarters) in Switzerland.
1996: Ciba-Geigy merged with Sandoz, with the pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were sold off, or, like Ciba Specialty Chemicals, were spun off as independent companies. The Sandoz brand disappeared for 3 years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France and Switzerland.
In addition to pharmaceutical companies (65 companies), Switzerland many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies). According to KPMG, there are 120 life science companies in Basel, 132 in Zürich and 92 in the Lemanic region.
In 2013, 41 life science companies have their international headquarters (and 29 more their regional headquarters) in Switzerland.